TSE:CRON

Cronos Group Inc. (CRON.TO) Stock Forecast, Price & News

C$13.67

-0.18 (-1.30 %)

(As of 01/21/2021 10:03 AM ET)

Add

Compare

Today's Range

C$13.59

Now: C$13.67▼

C$13.91

50-Day Range

C$8.84

MA: C$10.83▼

C$14.24

52-Week Range

C$5.82

Now: C$13.67▼

C$14.95

Volume152,157 shs

Average Volume1.18 million shs

Market CapitalizationC$4.87 billion

P/E Ratio47.63

Dividend YieldN/A

BetaN/A

Cronos Group Inc. operates as a cannabinoid company in the United States and internationally. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through ecommerce, retail, and hospitality partner channels. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. Its brand portfolio includes PEACE NATURALS, a global wellness platform; adult-use brands comprise COVE and Spinach; and hemp-derived CBD brands consists of Lord Jones and PEACE+. Cronos Group Inc. is based in Toronto, Canada.

MarketRank^™

Overall MarketRank^™

0.64 out of 5 stars

1.1 Analyst's Opinion

Consensus Rating
Cronos Group Inc. (CRON.TO) has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 2 buy ratings, 2 hold ratings, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of C$8.07, Cronos Group Inc. (CRON.TO) has a forecasted downside of 41.7% from its current price of C$13.85.
Amount of Analyst Coverage
Cronos Group Inc. (CRON.TO) has only been the subject of 1 research reports in the past 90 days.

2.1 Community Rank

Outperform Votes
Cronos Group Inc. (CRON.TO) has received 59 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Cronos Group Inc. (CRON.TO) has received 79 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Cronos Group Inc. (CRON.TO) has received 57.25% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Cronos Group Inc. (CRON.TO) and other stocks. Vote “Outperform” if you believe CRON will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CRON will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Cronos Group Inc. (CRON.TO) does not currently pay a dividend.
Dividend Growth
Cronos Group Inc. (CRON.TO) does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cronos Group Inc. (CRON.TO) insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Cronos Group Inc. (CRON.TO) is 48.26, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.67.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cronos Group Inc. (CRON.TO) is 48.26, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 35.92.
Price to Earnings Growth Ratio
Cronos Group Inc. (CRON.TO) has a PEG Ratio of 6.18. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Cronos Group Inc. (CRON.TO) has a P/B Ratio of 2.79. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange TSE

Industry Biotechnology

Sub-IndustryN/A

SectorMedical

Current SymbolTSE:CRON

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.thecronosgroup.com

Phone416-504-0004

Employees631

Debt

Debt-to-Equity Ratio0.56

Current Ratio9.75

Quick Ratio9.22

Price-To-Earnings

Trailing P/E Ratio47.63

Forward P/E RatioN/A

P/E Growth6.18

Sales & Book Value

Annual SalesC$36.98 million

Price / Sales131.66

Cash FlowC$3.68 per share

Price / Cash Flow3.72

Book ValueC$4.97 per share

Price / Book2.75

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares356,187,000

Market CapC$4.87 billion

Next Earnings DateN/A

OptionableOptionable

C$13.67

-0.18 (-1.30 %)

(As of 01/21/2021 10:03 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive CRON News and Ratings via Email

Sign-up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.

Cronos Group Inc. (CRON.TO) (TSE:CRON) Frequently Asked Questions

How has Cronos Group Inc. (CRON.TO)'s stock been impacted by COVID-19 (Coronavirus)?

Cronos Group Inc. (CRON.TO)'s stock was trading at C$7.45 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CRON shares have increased by 85.9% and is now trading at C$13.85.
View which stocks have been most impacted by COVID-19.

Is Cronos Group Inc. (CRON.TO) a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group Inc. (CRON.TO) in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Cronos Group Inc. (CRON.TO) stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRON, but not buy additional shares or sell existing shares.
View analyst ratings for Cronos Group Inc. (CRON.TO) or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Cronos Group Inc. (CRON.TO)?

Wall Street analysts have given Cronos Group Inc. (CRON.TO) a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cronos Group Inc. (CRON.TO) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What price target have analysts set for CRON?

5 Wall Street analysts have issued 12-month price objectives for Cronos Group Inc. (CRON.TO)'s stock. Their forecasts range from C$5.00 to C$11.00. On average, they expect Cronos Group Inc. (CRON.TO)'s share price to reach C$8.07 in the next twelve months. This suggests that the stock has a possible downside of 41.7%.
View analysts' price targets for Cronos Group Inc. (CRON.TO) or view Wall Street analyst' top-rated stocks.

Who are some of Cronos Group Inc. (CRON.TO)'s key competitors?

Some companies that are related to Cronos Group Inc. (CRON.TO) include Abcam plc (ABC.L) (ABC), MorphoSys AG (MOR.F) (MOR), BTG (BTG), Genus plc (GNS.L) (GNS), Trillium Therapeutics Inc. (TRIL.TO) (TRIL), Concordia International Corp. (CXR.TO) (CXR), PureTech Health (PRTC), Novacyt S.A. (NCYT.L) (NCYT), Oxford Biomedica plc (OXB.L) (OXB), Inventiva (IVA), Biotest Aktiengesellschaft (BIO.F) (BIO), Ergomed plc (ERGO.L) (ERGO), Aptose Biosciences (APS), Burcon NutraScience Co. (BU.TO) (BU) and BioTime (BTX).
View all of CRON's competitors.

What other stocks do shareholders of Cronos Group Inc. (CRON.TO) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group Inc. (CRON.TO) investors own include Aurora Cannabis Inc. (ACB.TO) (ACB), (CGC), Aurora Cannabis (ACB), Canopy Growth (WEED), NVIDIA (NVDA), Aphria Inc. (APHA.TO) (APHA), Advanced Micro Devices (AMD), Netflix (NFLX), The Walt Disney (DIS) and Intel (INTC).

Who are Cronos Group Inc. (CRON.TO)'s key executives?

Cronos Group Inc. (CRON.TO)'s management team includes the following people:

Mr. Michael Ryan Gorenstein, Exec. Chairman (Age 33, Pay $333.57k)
Mr. Jerry Filomena Barbato, Chief Financial Officer (Age 44, Pay $299.63k)
Ms. Xiuming Shum, Exec. VP of Legal and Regulatory Affairs & Corp. Sec. (Age 34, Pay $190.18k)
Mr. Kurt Thomas Schmidt B.Sc., M.B.A., Pres & CEO (Age 63)
Mr. Shayne J. Laidlaw, Director of Investor Relations & Strategy
Mr. Eric Klein, Head of Marketing
Ms. Shannon Buggy, Sr. VP & Global Head of People
Ms. Anna Shlimak, Sr. VP of Corp. Affairs (Age 34)
Dr. Todd K. Abraham, Chief Innovation Officer (Age 65)
Puneet Mathur, VP & Controller

What is Cronos Group Inc. (CRON.TO)'s stock symbol?

Cronos Group Inc. (CRON.TO) trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CRON."

How do I buy shares of Cronos Group Inc. (CRON.TO)?

Shares of CRON and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is Cronos Group Inc. (CRON.TO)'s stock price today?

One share of CRON stock can currently be purchased for approximately C$13.85.

How big of a company is Cronos Group Inc. (CRON.TO)?

Cronos Group Inc. (CRON.TO) has a market capitalization of C$4.93 billion and generates C$36.98 million in revenue each year. Cronos Group Inc. (CRON.TO) employs 631 workers across the globe.

What is Cronos Group Inc. (CRON.TO)'s official website?

The official website for Cronos Group Inc. (CRON.TO) is www.thecronosgroup.com.

How can I contact Cronos Group Inc. (CRON.TO)?

The company can be reached via phone at 416-504-0004.

This page was last updated on 1/21/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here